These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38042001)

  • 1. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy.
    Kuche K; Yadav V; Patel M; Chaudhari D; Date T; Jain S
    Biomater Adv; 2024 Jan; 156():213700. PubMed ID: 38042001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin.
    Kuche K; Yadav V; Dharshini M; Ghadi R; Chaudhari D; Date T; Jain S
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127254. PubMed ID: 37813219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety Assessment.
    Kuche K; Yadav V; Patel M; Ghadi R; Jain S
    AAPS PharmSciTech; 2023 Sep; 24(7):180. PubMed ID: 37697085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
    Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
    Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.
    Imanparast F; Faramarzi MA; Vatannejad A; Paknejad M; Deiham B; Kobarfard F; Amani A; Doosti M
    Microvasc Res; 2017 Jul; 112():14-19. PubMed ID: 28161429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Effect of Layered Double Hydroxides Nanodosage Form to Induce Apoptosis and Ferroptosis in Breast Cancer.
    Pang S; Geng C; Fan Z; Hou M; Mao H; Tao S; Wang J; Wu Y; Wei K; Li Y; Yan L; Yang Q; Chen C; Wang W
    Int J Nanomedicine; 2024; 19():4199-4215. PubMed ID: 38766657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
    Liu X; Zhu X; Qi X; Meng X; Xu K
    Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells.
    Wang CZ; Fu YC; Jian SC; Wang YH; Liu PL; Ho ML; Wang CK
    J Colloid Interface Sci; 2014 Oct; 432():190-9. PubMed ID: 25086394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a novel glioma therapy based on ferroptosis induced by layered double hydroxide loaded with simvastatin.
    Peng W; Qian Y; Qi X
    Environ Res; 2023 Dec; 238(Pt 2):117112. PubMed ID: 37717807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
    Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
    J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin Nanoparticles Inhibiting Ferroptosis for the Enhanced Treatment of Intracerebral Hemorrhage.
    Yang C; Han M; Li R; Zhou L; Zhang Y; Duan L; Su S; Li M; Wang Q; Chen T; Mo Y
    Int J Nanomedicine; 2021; 16():8049-8065. PubMed ID: 34938072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-Targeting Nanoparticles of a Dendritic (Aspartic acid)
    Lin CW; Lee CY; Lin SY; Kang L; Fu YC; Chen CH; Wang CK
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.
    Kurakula M; Naveen NR
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment.
    Mohaghegh N; Ahari A; Buttles C; Davani S; Hoang H; Huang Q; Huang Y; Hosseinpour B; Abbasgholizadeh R; Cottingham AL; Farhadi N; Akbari M; Kang H; Khademhosseini A; Jucaud V; Pearson RM; Hassani Najafabadi A
    ACS Nano; 2024 Oct; 18(40):27764-27781. PubMed ID: 39342648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis.
    Elakkad YE; Mohamed SNS; Abuelezz NZ
    Breast Cancer (Dove Med Press); 2021; 13():675-689. PubMed ID: 34934357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: Design, optimization and evaluation.
    Wang F; Shan Q; Chang X; Li Z; Gui S
    Int J Pharm; 2021 Jun; 602():120617. PubMed ID: 33887394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
    Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
    BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.